Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Recruiting	Phase 3	2020-09-28		NCT04453813

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Cancer Hospital & Institute of Guangzhou Medical University	33
Fifth Affiliated Hospital, Sun Yat-Sen University	41
Sun Yat-sen University	606
Wuzhou Red Cross Hospital	20
Yuebei People's Hospital	14
Zhongshan People's Hospital, Guangdong, China	46

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Center of Guangzhou Medical University	Guangzhou	China	3
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The Fifth Affiliated Hospital of Sun Yat-sen University	Zhuhai	China	21
Wuzhou Red Cross Hospital	Wuzhou	China	14
Yuebei People's Hospital	Shaoguan	China	3
Zhongshan People's Hospital	Zhongshan	China	14